Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)

By  

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3656-3661

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL

By  

Current Pharmaceutical Design, Vol. 20, Iss. 40, 2014-12 ,pp. : 6256-6269

Bentham Science Publishers

Access to resources Recommend Favorite

Inadequate response to aspirin associated with PlA2 homozygosity

By  

Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Metformin & lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effect

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 1011-1013

Informa Healthcare

Access to resources Recommend Favorite

Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese

By Yasumori T.   Narita H.   Matsuda T.   Takubo T.   Ogawa M.   Ishii M.   Hara K.   Ishii Y.   Okuyama K.   Fujimoto G.   Ochiai H.   Kano A.   Hasegawa S.   Sato K.   Taniguchi T.  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 939-946

Springer Publishing Company

Access to resources Recommend Favorite